Pharmaceutical compositions and dietary soybean food products for the prevention of osteoporosis
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 13, 1995
Grant Date -
N/A
app pub date -
Jun 10, 1994
filing date -
Jun 10, 1994
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A composition for the treatment or prevention of osteoporosis, is disclosed, which comprises: (a) 75 to 200 parts of one or more phytoestrogen compounds; (b) 0 to 100 parts of dried licorice root extract; (c) 300 to 600 parts of calcium contained in a biologically acceptable calcium salt; (d) 70 to 280 parts of magnesium contained in a biologically acceptable magnesium salt; (e) 4 to 25 parts of zinc contained in a biologically acceptable zinc salt; (f) 5 to 20 parts of beta-carotene; (g) 0.005 to 0.010 parts of Vitamin D as cholecalciferol; and (h) 6 to 12 parts of Vitamin E, in admixture with a biologically acceptable inert carrier. The new compositions are administered to a mammalian subject as either a pharmaceutical or as a dietary supplement.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully